Longitudinal assessment of utilities in patients with migraine: an analysis of erenumab randomized controlled trials

Overview of attention for article published in Health and Quality of Life Outcomes, November 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Dimensions has found 6 publications that cite this research output.

Article in PharmacoEconomics (June 2023)

Article in European Journal of Neurology (January 2023)

Article in Network Modeling Analysis in Health Informatics and Bioinformatics (December 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.